Home/ Supplements/ Electrolytes/ GH Pituitary Support Day Formula

GH Pituitary Support Day Formula

product on market Tablet or Pill Life Extension Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 25% of ingredients have research evidence
B Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

L-arginine and L-ornithine are studied for their role in amino acid synthesis, though evidence for growth hormone stimulation in healthy adults is limited. Cognizin CDP-choline is associated with cognitive support, while calcium is essential for various physiological functions. Overall, clinical evidence supporting this specific combination for pituitary support is sparse.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for GH Pituitary Support Day Formula
Open Full PDF View on NIH DSLD →
Details

Label Data

4 Tablet(s)
Serving Size
30
Servings
Other Combinations
Product Type
25%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Calcium
354 mg (35% DV)
800 mg
Market median: 500.0mg (143 products)
L-Ornithine
800 mg
Within RDA (0.5× RDA) 38 studies (A:1, B:7)

Other Ingredients

Microcrystalline Cellulose Croscarmellose Sodium Aqueous Film Coating Stearic Acid Silica Vegetable Stearate
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Read the entire label and follow the directions carefully prior to use. DIRECTIONS: Take four (4) tablets daily in the morning or before exercise, preferably on an empty stomach, or as recommended by a healthcare practitioner. May be used in addition to GH Pituitary Support Night Formula.

Warnings & Precautions

-DO NOT EXCEED RECOMMENDED DOSE. -Do not purchase if outer seal is broken or damaged.

-When using nutritional supplements, please consult with your physician if you are undergoing treatment for a medical condition or if you are pregnant or lactating.

WARNINGS: -Keep out of reach of children.

Formulation Notes

Day Formula

Additional Information

Store tightly closed in a cool, dry place.

Scan for product info

Q01301F

Promotes Optimal Pituitary Function For Body Composition Maintenance*

To report a serious adverse event or obtain product information, contact 1-866-280-2852.

Metadata

Product Details

UPC / SKU7 37870 13011 6
DSLD Entry Date2016-04-22
Product TypeOther Combinations
FormTablet or Pill
DSLD ID59067
Data Updated2026-04-11
Research

Research Evidence

849
Research Sources
56
Avg Quality
450
Meta Analysis
152
Rct
137
Systematic Review
73
Clinical Trial
11
Regulatory Source
7
Other
7
Guideline
3
Openfda Safety
2
Cochrane Review
2
Observational
A Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2015 PubMed DOI
A Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid and late life
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems
Meta Analysis The Cochrane database of systematic reviews 2025 PubMed DOI
A Dietary calcium supplementation for preventing colorectal cancer and adenomatous polyps
Systematic Review The Cochrane database of systematic reviews 2008 PubMed DOI
A Calcium and vitamin D for increasing bone mineral density in premenopausal women
Systematic Review The Cochrane database of systematic reviews 2023 PubMed DOI
A Dietary sodium, sodium-to-potassium ratio, and risk of stroke: A systematic review and nonlinear dose-response meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2019 PubMed DOI
A The association between circulating magnesium and clinically relevant outcomes in patients with chronic kidney disease: A systematic review and meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2021 PubMed DOI
A Calcium channel blockers versus other classes of drugs for hypertension
Systematic Review The Cochrane database of systematic reviews 2021 PubMed DOI
View all evidence for Electrolytes →
Compare

Similar Products

View all Electrolytes products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.